Related references
Note: Only part of the references are listed.DELAYED 131-I FIRST TREATMENT AFTER SURGERY HAS NO IMPACT ON THE MEDIAN TERM OUTCOME OF PATIENTS WITH INTERMEDIATE RISK DIFFERENTIATED THYROID CANCER
Antonio Matrone et al.
ENDOCRINE PRACTICE (2020)
Controversies, Consensus, and Collaboration in the Use of 131I Therapy in Differentiated Thyroid Cancer: A Joint Statement from the American Thyroid Association, the European Association of Nuclear Medicine, the Society of Nuclear Medicine and Molecular Imaging, and the European Thyroid Association
R. Michael Tuttle et al.
THYROID (2019)
Radioactive iodine in differentiated thyroid cancer: a national database perspective
Ryan K. Orosco et al.
ENDOCRINE-RELATED CANCER (2019)
Risk of recurrence in patients with papillary thyroid carcinoma and minimal extrathyroidal extension not treated with radioiodine
P. W. Rosario et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2019)
Second Radioiodine Treatment: Limited Benefit for Differentiated Thyroid Cancer With Locoregional Persistent Disease
Dania Hirsch et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Controversies in the Management of Low-Risk Differentiated Thyroid Cancer
Megan R. Haymart et al.
ENDOCRINE REVIEWS (2017)
Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013
Hyeyeun Lim et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Updated American Joint Committee on Cancer/Tumor-Node-Metastasis Staging System for Differentiated and Anaplastic Thyroid Cancer (Eighth Edition): What Changed and Why?
R. Michael Tuttle et al.
THYROID (2017)
Why the European Association of Nuclear Medicine has declined to endorse the 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer
Frederik A. Verburg et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Dynamic Risk Stratification in Patients with Differentiated Thyroid Cancer Treated Without Radioactive Iodine
Denise P. Momesso et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Timing of Radioactive Iodine Administration Does Not Influence Outcomes in Patients with Differentiated Thyroid Carcinoma
Rafael Selbach Scheffel et al.
THYROID (2016)
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
Bryan R. Haugen et al.
THYROID (2016)
A Prospective Study Showing an Excellent Response of Patients with Low-Risk Differentiated Thyroid Cancer Who Did Not Undergo Radioiodine Remnant Ablation after Total Thyroidectomy
Carolina C. P. S. Janovsky et al.
EUROPEAN THYROID JOURNAL (2016)
Analysis of Age and Disease Status as Predictors of Thyroid Cancer-Specific Mortality Using the Surveillance, Epidemiology, and End Results Database
Ryan K. Orosco et al.
THYROID (2015)
Patterns of Use and Cost for Inappropriate Radioactive Iodine Treatment for Thyroid Cancer in the United States: Use and Misuse
Paolo Goffredo et al.
JAMA INTERNAL MEDICINE (2015)
Papillary Thyroid Cancer: Time Course of Recurrences During Postsurgery Surveillance
Cosimo Durante et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Impact on Overall Survival of Radioactive Iodine in Low-Risk Differentiated Thyroid Cancer Patients
Claire Schvartz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
The SNMMI Practice Guideline for Therapy of Thyroid Disease with 131I 3.0
Edward B. Silberstein et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
No survival difference after successful 131I ablation between patients with initially low-risk and high-risk differentiated thyroid cancer
Frederik Anton Verburg et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
The Effectiveness of Radioactive Iodine for Treatment of Low-Risk Thyroid Cancer: A Systematic Analysis of the Peer-Reviewed Literature from 1966 to April 2008
Wendy Sacks et al.
THYROID (2010)
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
David S. Cooper et al.
THYROID (2009)
An updated systematic review and commentary examining the effectiveness of radioactive iodine remnant ablation in well-differentiated thyroid cancer
Anna M. Sawka et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2008)
Guidelines for radioiodine therapy of differentiated thyroid cancer
M. Luster et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium
Furio Pacini et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2006)
Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): Temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients
ID Hay et al.
WORLD JOURNAL OF SURGERY (2002)
Share Paper
